InhaleRx (ASX:IRX) Short-Term Debt : A$0.09 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Short-Term Debt?

InhaleRx's Short-Term Debt for the quarter that ended in Jun. 2023 was A$0.09 Mil.

InhaleRx's quarterly Short-Term Debt stayed the same from Jun. 2022 (A$0.00 Mil) to Dec. 2022 (A$0.00 Mil) but then increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.09 Mil).

InhaleRx's annual Short-Term Debt stayed the same from Dec. 2021 (A$0.00 Mil) to Dec. 2022 (A$0.00 Mil) but then increased from Dec. 2022 (A$0.00 Mil) to Dec. 2023 (A$0.56 Mil).

InhaleRx Short-Term Debt Historical Data

The historical data trend for InhaleRx's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Short-Term Debt Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

0.56

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial									-	-	-	0.09	0.56

InhaleRx Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

InhaleRx Short-Term Debt Related Terms

Thank you for viewing the detailed overview of InhaleRx's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines